Published in Ann Chir on January 01, 1994
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med (1997) 8.72
Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology (1990) 4.78
Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res (1993) 1.98
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol (2009) 1.93
Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines. Ann Oncol (1996) 1.76
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy. J Clin Oncol (1997) 1.67
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. Ann Oncol (2002) 1.61
Sonographic assessment of the normal and abnormal bowel wall in nondiverticular ileitis and colitis. Abdom Imaging (1997) 1.50
The impact of nonvisualization of sentinel nodes on lymphoscintigraphy in breast cancer. Ann Surg Oncol (2005) 1.45
Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours. Br J Dermatol (2004) 1.44
Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab Dispos (1991) 1.43
[Severe ischemic hepatitis after taking cibenzoline]. Ann Gastroenterol Hepatol (Paris) (1991) 1.40
Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol (2005) 1.39
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study. Radiother Oncol (1997) 1.38
Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. J Clin Oncol (1998) 1.34
A compact portable prosthesis for total parenteral nutrition (T.P.N.) : ambulatory parenteral feeding in the hospital and home. Acta Chir Scand Suppl (1976) 1.31
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer (1993) 1.23
HDL-cholesterol and breast cancer: a joint study in northern Italy and southern France. Int J Epidemiol (1993) 1.22
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy. Br J Cancer (2009) 1.22
Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. Eur J Cancer (1994) 1.21
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18
Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies. Cancer Treat Rev (2013) 1.16
Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results. Ann Surg (1995) 1.15
Immunosuppressive effect of rifampicin. Transplantation (1972) 1.11
Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors. Ann Oncol (1997) 1.10
Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut (2011) 1.08
Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. World J Gastroenterol (2007) 1.06
Colorectal carcinoma in patients younger than 40 years of age. Montpellier Cancer Institute experience with 78 patients. Cancer (1988) 1.02
A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol. Cancer (1993) 1.02
Intestinal adaptation in patients with short bowel syndrome. Measurement by calcium absorption. Dig Dis Sci (1989) 1.01
Osseous metastases in the hand. A general review of three cases. Ann Chir Main (1982) 1.01
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1996) 1.00
Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d'Etude des Néoplasies Endocriniennes Multiples (GENEM and groupe de Recherche et d'Etude du Syndrome de Zollinger-Ellison (GRESZE). Gastroenterology (1999) 0.99
Male breast cancer and the androgen receptor gene. Nat Genet (1993) 0.96
G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. Br J Cancer (2004) 0.96
Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors. Ann Oncol (2003) 0.95
The antiprogestin RU486 in advanced breast cancer: preliminary clinical trial. Bull Cancer (1987) 0.95
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas. Br J Cancer (2008) 0.95
Androgen receptor gene mutation in male breast cancer. Hum Mol Genet (1993) 0.94
Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer (2004) 0.94
[Anorectal malignant melanomas. Apropos of 5 cases. Review of the literature]. Ann Gastroenterol Hepatol (Paris) (1995) 0.94
Relationship between rectal sensitivity, symptoms intensity and quality of life in patients with irritable bowel syndrome. Aliment Pharmacol Ther (2008) 0.94
[Immunosuppressive action of rifampicin]. Nouv Presse Med (1972) 0.94
A prospective randomized study comparing high- and low-dose leucovorin combined with same-dose 5-fluorouracil in advanced colorectal cancer. Am J Clin Oncol (1998) 0.94
Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness. Eur J Cancer (1990) 0.94
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer. Br J Cancer (2009) 0.94
p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. Br J Cancer (2005) 0.93
Randomized clinical trial comparing axillary padding with closed suction drainage for the axillary wound after lymphadenectomy for breast cancer. Br J Surg (2006) 0.93
[Breast cancer in women with trisomy 21]. Bull Acad Natl Med (2001) 0.92
Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorectal Dis (2006) 0.92
Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology (1983) 0.91
A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol (1997) 0.91
Tumor progression and oxidant-antioxidant status. Carcinogenesis (1996) 0.90
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors. Support Care Cancer (2012) 0.90
In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers. Cancer Res (1990) 0.90
New techniques for long-term intravenous feeding: an artificial gut in 75 patients. Ann Surg (1974) 0.90
Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol (2003) 0.89
Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum. Eur J Cancer (1994) 0.89
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6. Oncology (2011) 0.89
Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study. Ann Oncol (2014) 0.88
Anal sphincter reconstruction by dynamic graciloplasty after abdominoperineal resection for cancer. Dis Colon Rectum (1999) 0.88
Recurrences of rectal cancers: results of a multimodal approach with intraoperative radiation therapy. French Group of IORT. Intraoperative Radiation Therapy. Int J Radiat Oncol Biol Phys (1996) 0.88
Cancer of the uterine cervix: dosimetric guidelines for prevention of late rectal and rectosigmoid complications as a result of radiotherapeutic treatment. Int J Radiat Oncol Biol Phys (1982) 0.88
Alcohol consumption in a case-control study of breast cancer in southern France. Int J Cancer (1989) 0.88
[Long-term parenteral hypernutrition. Use in cancerous cachexia]. Chirurgie (1972) 0.88
Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid. Eur J Cancer (1999) 0.88
Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum. Gastroenterology (1992) 0.87
Personality dimensions in social phobics with or without depression. Acta Psychiatr Scand (2002) 0.87
Relationship between vitamin E and polyunsaturated fatty acids in breast cancer. Nutritional and metabolic aspects. Cancer (1989) 0.87
Coelioscopic treatment of perforated gastroduodenal ulcer using the ligamentum teres hepatis. Surg Endosc (1991) 0.86
Body dysmorphic disorder in a sample of cosmetic surgery applicants. Eur Psychiatry (2003) 0.86
Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha. Cancer Res (1996) 0.86
Immunoenzymatic assay of Mr 52,000 cathepsin D in 182 breast cancer cytosols: low correlation with other prognostic parameters. Cancer Res (1988) 0.86
Exclusive radical radiation therapy in breast carcinoma. Radiother Oncol (1991) 0.86
Sonographic diagnosis of colitis in children. Eur Radiol (2004) 0.85
Conservative treatment for low rectal carcinoma by local excision with or without radiotherapy. Br J Surg (1993) 0.85
Oxidant-antioxidant status alterations in cancer patients: relationship to tumor progression. J Nutr (1996) 0.84
[New technics of long term parenteral feeding for intestinal replacement. Use of an artificial intestine in 54 cases]. J Chir (Paris) (1973) 0.84
Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer. Eur J Cancer (1990) 0.84
Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancer. Anticancer Res (2003) 0.84
Variation of bcl-2 expression in breast ducts and lobules in relation to plasma progesterone levels: overexpression and absence of variation in fibroadenomas. J Pathol (1997) 0.84